Savior LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-289
Closed -$15.3K 27
2023
Q3
$15.3K Hold
289
0.11% 54
2023
Q2
$15.6K Hold
289
0.06% 58
2023
Q1
$14.5K Hold
289
0.01% 79
2022
Q4
$13.4K Hold
289
0.01% 92
2022
Q3
$11K Hold
289
0.01% 121
2022
Q2
$11K Hold
289
0.01% 103
2022
Q1
$13K Hold
289
0.01% 99
2021
Q4
$12K Sell
289
-116
-29% -$4.87K ﹤0.01% 106
2021
Q3
$18K Sell
405
-220
-35% -$9.73K 0.02% 88
2021
Q2
$27K Hold
625
0.02% 240
2021
Q1
$24K Hold
625
0.02% 258
2020
Q4
$22K Buy
625
+94
+18% +$3.39K 0.02% 268
2020
Q3
$20K Hold
531
0.02% 257
2020
Q2
$19K Hold
531
0.02% 241
2020
Q1
$17K Hold
531
0.02% 232
2019
Q4
$24K Buy
+531
New +$22.2K 0.03% 263

Other funds holding BSX

Savior LLC's BSX Position: Q4 2023 in Review

Savior LLC sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 289 shares — an estimated $15.3K sold.

Savior LLC first reported a position in BSX in Q4 2019 and held it in 16 quarters. The position peaked at $27K in Q2 2021. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

  • Savior LLC reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
  • Savior LLC sold 289 Boston Scientific shares in Q4 2023, an estimated $15.3K.
  • Savior LLC first reported a position in Boston Scientific in Q4 2019 and held it in 16 quarters.
  • Savior LLC's Boston Scientific position peaked at $27K in Q2 2021.
  • 1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Savior LLC's 13F filing for Q4 2023, filed 1 Feb 2024.